Life Science Big News Roundup: PreveCeutical Reaches Milestone in Research Program for Non-Addictive Analgesics; Therma Bright’s TherOZap(TM) Technology Test Results Prove Successful at Inhibiting Zika Virus Life Science Investing
Nabriva Therapeutics Receives $5M Payment Under License Agreement with Sinovant Sciences Biotech Investing
Therma Bright’s International Patent Application for TherOZap(TM) Enters National Phases in the US, Europe & Canada Cannabis Investing News